{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:26:51Z","timestamp":1787585211497,"version":"build-2736575974"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Effective glioblastoma care requires integrating multiparametric longitudinal MRI with histopathology, molecular profiling, and clinical records documenting surgery, radiotherapy, chemotherapy, and supportive treatments. In routine practice, however, these data streams are often evaluated separately rather than jointly, which can delay molecularly informed stratification, limit reproducibility across centers, and complicate interpretation of post-treatment imaging changes. Multimodal machine learning (MML) provides a framework for clinical decision support by integrating diverse patient data across the course of care, from symptom presentation through diagnosis to treatment decisions. By combining MRI, whole-slide pathology, molecular and methylation profiling, and treatment timelines derived from electronic health records, MML models can capture disease characteristics over time across biological scales through representation learning and multimodal fusion. Importantly, these approaches can incorporate uncertainty through model calibration and confidence-aware predictions. When rigorously developed and validated, MML models may generate clinically relevant outputs, including integrated diagnosis, molecular classification, individualized survival estimates, probabilistic discrimination between tumor progression and pseudo-progression, and stratification for clinical trial eligibility. In this Mini Review, we summarize recent advances and emerging translational evidence for clinically oriented MML in glioblastoma, with particular emphasis on MRI-centered systems that integrate imaging with pathology, selected molecular measurements, and longitudinal clinical context. We also outline key methodological and practical considerations, including dataset curation, leakage control, external validation, calibration, and post-deployment monitoring\u2014required to support safe, robust, and generalizable implementation of MML approaches in neuro-oncology practice.<\/jats:p>","DOI":"10.3389\/fonc.2026.1912365","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:43:20Z","timestamp":1787582600000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From data silos to integrated diagnosis: multimodal machine learning in glioblastoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Amin","family":"Zadeh-Shirazi","sequence":"first","affiliation":[{"name":"Centre for Cancer Biology, Adelaide University","place":["Adelaide, SA, Australia"]},{"name":"Department of Computer Engineering, Faculty of Engineering, Khayyam University","place":["Mashhad, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan W.","family":"Day","sequence":"additional","affiliation":[{"name":"Sid Faithfull Brain Cancer Laboratory, QIMR Berghofer","place":["Brisbane, QLD, Australia"]},{"name":"School of Biomedical Sciences, The University of Queensland","place":["Brisbane, QLD, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui K.","family":"Gan","sequence":"additional","affiliation":[{"name":"Cancer Therapies and Biology Group, Centre of Research Excellence in Brain Tumours, Olivia Newton-John Cancer Wellness and Research Centre, Austin Hospital","place":["Heidelberg, Melbourne, VIC, Australia"]},{"name":"La Trobe University School of Cancer Medicine, and Department of Medicine, University of Melbourne","place":["Heidelberg, Melbourne, VIC, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo A.","family":"Gomez","sequence":"additional","affiliation":[{"name":"Centre for Cancer Biology, Adelaide University","place":["Adelaide, SA, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.07.004","article-title":"Pan-cancer integrative histology-genomic analysis via multimodal deep learning","volume":"40","author":"Chen","year":"2022","journal-title":"Cancer Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/frai.2024.1408843","article-title":"Multimodal data integration for oncology in the era of deep neural networks: a review","volume":"7","author":"Waqas","year":"2024","journal-title":"Front Artif Intell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae699","article-title":"Multimodal deep learning approaches for precision oncology: a comprehensive review","volume":"26","author":"Yang","year":"2025","journal-title":"Briefings Bioinf"},{"key":"B4","doi-asserted-by":"publisher","first-page":"105663","DOI":"10.1016\/j.ebiom.2025.105663","article-title":"Deep learning informed multimodal fusion of radiology and pathology to predict outcomes in HPV-associated oropharyngeal squamous cell carcinoma","volume":"114","author":"Song","year":"2025","journal-title":"EBioMedicine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41746-025-02257-y","article-title":"Multimodal deep learning for cancer prognosis prediction with clinical information prompts integration","volume":"9","author":"Hou","year":"2026","journal-title":"NPJ Digital Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s43856-023-00276-y","article-title":"Multimodal deep learning to predict prognosis in adult and pediatric brain tumors","volume":"3","author":"Steyaert","year":"2023","journal-title":"Commun Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdae122","article-title":"Comprehensive multimodal deep learning survival prediction enabled by a transformer architecture: A multicenter study in glioblastoma","volume":"6","author":"Gomaa","year":"2024","journal-title":"Neuro-Oncology Adv"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-023-04439-8","article-title":"Predicting survival in glioblastoma with multimodal neuroimaging and machine learning","volume":"164","author":"Luckett","year":"2023","journal-title":"J Neuro-Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.compmedimag.2022.102167","article-title":"A literature survey of MR-based brain tumor segmentation with missing modalities","volume":"104","author":"Zhou","year":"2023","journal-title":"Comput Med Imaging Graphics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.a4544","article-title":"Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials","volume":"17","author":"Ellingson","year":"2015","journal-title":"Neuro-oncology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcdb.2024.12.006","article-title":"Spatial omics shed light on the tumour organisation of glioblastoma","volume":"167","author":"Whittle","year":"2025","journal-title":"Semin Cell Dev Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-oncology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaf201.1012","article-title":"Advancing CNS tumor diagnostics with expanded DNA methylation-based classification","volume":"44","author":"Sill","year":"2026","journal-title":"Cancer Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.04.004","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1219747110","article-title":"Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics","volume":"110","author":"Sottoriva","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3590","article-title":"Clonal evolution of glioblastoma under therapy","volume":"48","author":"Wang","year":"2016","journal-title":"Nat Genet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2017.11.024","article-title":"Harmonization of cortical thickness measurements across scanners and sites","volume":"167","author":"Fortin","year":"2018","journal-title":"Neuroimage"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1109\/ISBI.2009.5193250","article-title":"A method for normalizing histology slides for quantitative analysis","author":"Macenko","year":"2009"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+ AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e082505","DOI":"10.1136\/bmj-2024-082505","article-title":"PROBAST+ AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods","volume":"388","author":"Moons","year":"2025","journal-title":"BMJ"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e070904","DOI":"10.1136\/bmj-2022-070904","article-title":"Reporting guideline for the early stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI","volume":"377","author":"Vasey","year":"2022","journal-title":"BMJ"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e081554","DOI":"10.1136\/bmj-2024-081554","article-title":"FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare","volume":"388","author":"Lekadir","year":"2025","journal-title":"BMJ"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02856-4","article-title":"A visual-language foundation model for computational pathology","volume":"30","author":"Lu","year":"2024","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07894-z","article-title":"A pathology foundation model for cancer diagnosis and prognosis prediction","volume":"634","author":"Wang","year":"2024","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08378-w","article-title":"A vision\u2013language foundation model for precision oncology","volume":"638","author":"Xiang","year":"2025","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"17133","DOI":"10.1038\/s41598-025-02026-7","article-title":"A self-supervised multimodal deep learning approach to differentiate post-radiotherapy progression from pseudoprogression in glioblastoma","volume":"15","author":"Gomaa","year":"2025","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"8784","DOI":"10.1038\/s41598-022-12699-z","article-title":"Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma","volume":"12","author":"Fathi Kazerooni","year":"2022","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081148","article-title":"Integration of radiomic and multi-omic analyses predicts survival of newly diagnosed IDH1 wild-type glioblastoma","volume":"11","author":"Chaddad","year":"2019","journal-title":"Cancers"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.791776","article-title":"Radiomics analysis based on magnetic resonance imaging for preoperative overall survival prediction in isocitrate dehydrogenase wild-type glioblastoma","volume":"15","author":"Wang","year":"2022","journal-title":"Front Neurosci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16193351","article-title":"Reproducible and interpretable machine learning-based radiomic analysis for overall survival prediction in glioblastoma multiforme","volume":"16","author":"Duman","year":"2024","journal-title":"Cancers"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030589","article-title":"Multiparametric radiogenomic model to predict survival in patients with glioblastoma","volume":"16","author":"Mahmoudi","year":"2024","journal-title":"Cancers"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1912365\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:43:21Z","timestamp":1787582601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1912365\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":36,"alternative-id":["10.3389\/fonc.2026.1912365"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1912365","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"article-number":"1912365"}}